“Rituximab in the Treatment of Refractory Myasthenia Gravis: Studying the Outcomes Using MMT Score And Need for Plasmapheresis in Baghdad Teaching Hospital”, Indian Journal of Forensic Medicine & Toxicology, vol. 14, no. 2, pp. 2505–2510, Apr. 2020, doi: 10.37506/ijfmt.v14i2.3485.